We are live on
!
Find out more
MACM
March Altus Capital Management Portfolio holdings
AUM
$16M
1-Year Est. Return
18.92%
This Fund
S&P 500
This Quarter
Est. Return
+22.67%
1 Year Est. Return
+18.92%
3 Year Est. Return
+155.68%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$330M
AUM Growth
–
Cap. Flow
+$304M
Cap. Flow
% of AUM
92.2%
Top 10 Holdings %
Top 10 Hldgs %
51.11%
Holding
28
New
28
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
DexCom
DXCM
|
+$26.4M |
| 2 |
MON
Monsanto Co
MON
|
+$21.7M |
| 3 |
Alkermes
ALKS
|
+$17.1M |
| 4 |
HCA Healthcare
HCA
|
+$17M |
| 5 |
West Pharmaceutical
WST
|
+$15.8M |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 75.36% |
| 2 | Financials | 8.92% |
| 3 | Materials | 7.02% |
| 4 | Industrials | 2.7% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
DexCom
DXCM
$28.8B
| $29.6M | 8.95% |
+3,339,352
| New | +$26.4M |
|
|
MON
2
DELISTED
Monsanto Co
MON
| $23.2M | 7.02% |
+198,988
| New | +$21.7M |
|
|
3
Alkermes
ALKS
$8.39B
| $18.8M | 5.7% |
+462,853
| New | +$17.1M |
|
|
4
HCA Healthcare
HCA
$85.7B
| $17.5M | 5.31% |
+367,390
| New | +$17M |
|
|
5
West Pharmaceutical
WST
$23.9B
| $16.5M | 5.01% |
+337,161
| New | +$15.8M |
|
|
ZLTQ
6
DELISTED
ZELTIQ Aesthetics, Inc.
ZLTQ
| $14.3M | 4.33% |
+756,505
| New | +$10.8M |
|
7
Aon
AON
$78.3B
| $12.3M | 3.73% |
+146,694
| New | +$11.6M |
|
8
Integra LifeSciences
IART
$1.33B
| $12.2M | 3.69% |
+624,844
| New | +$11.5M |
|
|
ALXN
9
DELISTED
Alexion Pharmaceuticals
ALXN
| $12.2M | 3.68% |
+91,411
| New | +$11M |
|
10
Baxter International
BAX
$13.8B
| $12.1M | 3.67% |
+321,015
| New | +$11.6M |
|
11
Universal Health Services
UHS
$9.88B
| $11.7M | 3.56% |
+144,506
| New | +$11.5M |
|
|
AGN
12
DELISTED
Allergan Inc
AGN
| $11.7M | 3.55% |
+105,645
| New | +$10.1M |
|
13
Humana
HUM
$44B
| $11.6M | 3.52% |
+112,502
| New | +$11M |
|
14
Eli Lilly
LLY
$1.03T
| $11.6M | 3.5% |
+226,838
| New | +$11.4M |
|
|
MNK
15
DELISTED
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
| $11.6M | 3.5% |
+221,085
| New | +$10.5M |
|
16
eHealth
EHTH
$43.8M
| $11.3M | 3.43% |
+243,399
| New | +$10.1M |
|
17
Perrigo
PRGO
$1.43B
| $11.2M | 3.39% |
+72,955
| New | +$10.5M |
|
18
Tandem Diabetes Care
TNDM
$1.3B
| $11M | 3.34% |
+42,802
| New | +$9.79M |
|
|
CYBX
19
DELISTED
CYBERONICS INC
CYBX
| $10.9M | 3.31% |
+166,888
| New | +$10.1M |
|
20
Encompass Health
EHC
$11B
| $10.5M | 3.19% |
+397,793
| New | +$11.1M |
|
|
ATHN
21
DELISTED
Athenahealth, Inc.
ATHN
| $8.91M | 2.7% |
+66,226
| New | +$8.51M |
|
|
UNIS
22
DELISTED
Unilife Corporation
UNIS
| $7.38M | 2.24% |
+167,743
| New | +$6.14M |
|
23
Accuray
ARAY
$33.9M
| $5.98M | 1.81% |
+686,569
| New | +$5.33M |
|
|
MDCO
24
DELISTED
Medicines Co
MDCO
| $5.9M | 1.79% |
+152,809
| New | +$5.46M |
|
|
MRSH
25
Marsh
MRSH
$91.4B
| $5.82M | 1.76% |
+120,350
| New | +$5.58M |
|
Similar funds
IC
PA
GMIM
JHWCP
SMPIAI
NCMG
CAD
GPI
March Altus Capital Management's Q4 2013 Portfolio in Review
Q4 2013 is the first quarter with a 13F filing on record for March Altus Capital Management, which disclosed 28 positions worth $330M. Its ten largest holdings account for 51% of the portfolio.
Its largest position is DexCom: 3,339,352 shares worth $29.6M.
By sector, the portfolio is most concentrated in Healthcare at 75% of assets, followed by Financials and Materials.
- March Altus Capital Management's largest Q4 2013 buy was DexCom: 3,339,352 shares worth $29.6M.
- March Altus Capital Management's ten largest holdings make up 51% of its $330M portfolio in Q4 2013.
- March Altus Capital Management disclosed 28 positions in Q4 2013, its first 13F filing on record.
Based on March Altus Capital Management's 13F filing for Q4 2013, filed 14 Feb 2014.